Health care resource use and costs among patients with cushing disease

Brooke Swearingen1, Ning Wu, Shih-Yin Chen

  • 1Neuroendocrine Clinical Center, Massachusetts General Hospital, Boston, Massachusetts, USA. BSwearingen@partners.org

Insights

Patients with Cushing disease incur higher health care costs due to comorbidities. Successful surgery reduces these costs, while unsuccessful surgery increases them, highlighting the economic impact of treatment outcomes.

Area of Science:

  • Endocrinology
  • Health Economics
  • Surgical Outcomes

Background:

  • Cushing disease is associated with significant comorbidities.
  • Understanding the economic burden of Cushing disease is crucial for healthcare planning.

Purpose of the Study:

  • To evaluate healthcare expenditures in Cushing disease patients.
  • To determine the impact of surgical treatment on overall and comorbidity-related costs.

Main Methods:

  • Retrospective cohort study using insurance claims data (2004-2008).
  • Patients with Cushing disease were matched with controls (nonfunctioning pituitary adenomas and population controls).
  • Analysis of comorbidities and annual direct healthcare costs, comparing pre- and post-operative periods based on remission status.

Main Results:

  • Cushing disease patients exhibited higher rates of hypertension, diabetes mellitus, and hyperlipidemia.
  • Total annual healthcare costs were significantly higher for Cushing disease patients compared to controls.
  • Successful surgery led to decreased outpatient costs and a trend of reduced overall costs; unsuccessful surgery correlated with increased postoperative costs.

Conclusions:

  • Cushing disease patients present with more comorbidities and higher healthcare costs.
  • Surgical success in Cushing disease is linked to reduced healthcare expenditures.
  • Treatment failure results in increased healthcare costs, emphasizing the importance of effective surgical intervention.
Abstract

Related Concept Videos

Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: